-
1
-
-
0027304738
-
Dissociation of the pore forming and phospholipase D activities stimulated via P2Z purinergic receptors in BAC1.2F5 macrophages
-
El-Moatassim C., Dubyak G.R. Dissociation of the pore forming and phospholipase D activities stimulated via P2Z purinergic receptors in BAC1.2F5 macrophages. J. Biol. Chem. 1993, 268:15571-15578.
-
(1993)
J. Biol. Chem.
, vol.268
, pp. 15571-15578
-
-
El-moatassim, C.1
Dubyak, G.R.2
-
2
-
-
0029088454
-
Pharmacological characterization of heterologously expressed ATP-gated cation channels (P2X purinoceptors)
-
Evans R.J., Lewis C., Buell G., Valera S., North R.A., Surprenant A. Pharmacological characterization of heterologously expressed ATP-gated cation channels (P2X purinoceptors). Mol. Pharmacol. 1995, 48:178-183.
-
(1995)
Mol. Pharmacol.
, vol.48
, pp. 178-183
-
-
Evans, R.J.1
Lewis, C.2
Buell, G.3
Valera, S.4
North, R.A.5
Surprenant, A.6
-
3
-
-
0027530024
-
Oxidized ATP, an irreversible inhibitor of the macrophage purinergic P2Z receptor
-
Murgia M., Hanau S., Pixzzo P., Rippa M., Di Virgilio F. Oxidized ATP, an irreversible inhibitor of the macrophage purinergic P2Z receptor. J. Biol. Chem. 1993, 268:8199-8203.
-
(1993)
J. Biol. Chem.
, vol.268
, pp. 8199-8203
-
-
Murgia, M.1
Hanau, S.2
Pixzzo, P.3
Rippa, M.4
Di Virgilio, F.5
-
4
-
-
0029665112
-
The cytosolic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7)
-
Surprenant A., Rassendren F., Kawashima E., North R.A., Buell G. The cytosolic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science 1996, 272:735-738.
-
(1996)
Science
, vol.272
, pp. 735-738
-
-
Surprenant, A.1
Rassendren, F.2
Kawashima, E.3
North, R.A.4
Buell, G.5
-
5
-
-
0028182521
-
The P2Z purinoceptor of human lymphocytes: actions of nucleotide agonists and irreversible antagonism by oxidized ATP
-
Wiley J.S., Chen J.R., Snook M.B., Jamieson G.P. The P2Z purinoceptor of human lymphocytes: actions of nucleotide agonists and irreversible antagonism by oxidized ATP. Br. J. Pharmacol. 1994, 112:946-950.
-
(1994)
Br. J. Pharmacol.
, vol.112
, pp. 946-950
-
-
Wiley, J.S.1
Chen, J.R.2
Snook, M.B.3
Jamieson, G.P.4
-
6
-
-
0037068428
-
Purine and pyrimidine (P2) receptors as drug targets
-
Jacobson, K.A., Jarvis, M.F. and Williams, M., Purine and pyrimidine (P2) receptors as drug targets, J. Med. Chem., 45 (2002) 4057-4093.
-
(2002)
J. Med. Chem.
, vol.45
, pp. 4057-4093
-
-
Jacobson, K.A.1
Jarvis, M.F.2
Williams, M.3
-
7
-
-
0035107660
-
International Union of Pharmacology. XXI V. Current status of the nomenclature and properties of P2X receptors and their subunits
-
Khakh, B.S., Burnstock, G., Kennedy, C., King, B.F., North, A.N., Seguela, P., Voigt, M. and Humphrey, P.P.A., International Union of Pharmacology. XXI V. Current status of the nomenclature and properties of P2X receptors and their subunits, Pharmacol. Rev., 53 (2001) 107-118.
-
(2001)
Pharmacol. Rev.
, vol.53
, pp. 107-118
-
-
Khakh, B.S.1
Burnstock, G.2
Kennedy, C.3
King, B.F.4
North, A.N.5
Seguela, P.6
Voigt, M.7
Humphrey, P.P.A.8
-
8
-
-
0036025118
-
Structure-activity relationships of suramin and pyridoxal-5'-phosphate derivatives as P2 receptor antagonists
-
Lambrecht, G., Braun, K., Damer, S., Ganso, M., Hildebrandt, C., Ullmann, H., Kassack, M.U. and Nickel, P., Structure-activity relationships of suramin and pyridoxal-5'-phosphate derivatives as P2 receptor antagonists, Current Pharmaceutical Design, 8 (2002) 2371-2399.
-
(2002)
Current Pharmaceutical Design
, vol.8
, pp. 2371-2399
-
-
Lambrecht, G.1
Braun, K.2
Damer, S.3
Ganso, M.4
Hildebrandt, C.5
Ullmann, H.6
Kassack, M.U.7
Nickel, P.8
-
9
-
-
0031754497
-
Receptors for purines and pyrimidines
-
Ralevic, V. and Burnstock, G., Receptors for purines and pyrimidines, Pharmacol. Rev., 50 (1998) 413-492.
-
(1998)
Pharmacol. Rev.
, vol.50
, pp. 413-492
-
-
Ralevic, V.1
Burnstock, G.2
|